Skip to main content
Top
Published in: Supportive Care in Cancer 4/2011

01-04-2011 | Short Communication

Cancer control—a global challenge requiring collaborative solutions

Author: Simon B. Sutcliffe

Published in: Supportive Care in Cancer | Issue 4/2011

Login to get access

Excerpt

In 2008, there were 12.4 million new cases of cancer worldwide and 7.6 million cancer deaths. It is projected that there will be between 20–26.4 million new cases and 12.9–17.0 million cancer deaths by 2030 (low estimates are based on no change in underlying rates; high estimates are based on an assumption of 1% increase per annum in the cancer incidence rate)[1]. The number of cancer cases worldwide doubled in the last third of the 20th century and will double again between 2008 and 2030 [1]. While the global average mortality:incidence ratio approximates 65%, this ratio ranges from 45% in Westernized, high-resource nations to >90% in resource-challenged countries. Five-year survival rates posttreatment of cancer range from 65% and an acknowledgement that cancer is becoming a chronic disease in high-resource nations, to a situation where cancer is almost invariably a fatal disease with little access to therapy or symptom control for most of the world's population [2]..
Literature
1.
go back to reference Boyle P, Levin B (eds) (2008) World cancer report 2008. International Agency for Research on Cancer, Lyon Boyle P, Levin B (eds) (2008) World cancer report 2008. International Agency for Research on Cancer, Lyon
2.
go back to reference Ferlay J, Bray F, Pisani P, Parkin M (2004) Globocan 2002: cancer incidence, mortality and prevalence worldwide. IARC Cancer Base no. 5, version 2.0 IARC Press, Lyon Ferlay J, Bray F, Pisani P, Parkin M (2004) Globocan 2002: cancer incidence, mortality and prevalence worldwide. IARC Cancer Base no. 5, version 2.0 IARC Press, Lyon
3.
go back to reference Kanavos P (2006) The rising burden of cancer in the developing world. Ann Oncol 17(8):viii5–viii23CrossRef Kanavos P (2006) The rising burden of cancer in the developing world. Ann Oncol 17(8):viii5–viii23CrossRef
4.
go back to reference World Health Organization (2005) Preventing chronic disease: a vital investment. WHO, Geneva World Health Organization (2005) Preventing chronic disease: a vital investment. WHO, Geneva
5.
go back to reference Elwood M, Sutcliffe SB (2010) Cancer control and the burden of cancer. In: Elwood M, Sutcliffe SB (eds) Cancer control. Oxford University Press, Oxford, 3–19 Elwood M, Sutcliffe SB (2010) Cancer control and the burden of cancer. In: Elwood M, Sutcliffe SB (eds) Cancer control. Oxford University Press, Oxford, 3–19
7.
go back to reference Bhanojirao VV (1991) Human development report 1990: review and assessment. World Dev 19(10):1451–1460CrossRef Bhanojirao VV (1991) Human development report 1990: review and assessment. World Dev 19(10):1451–1460CrossRef
9.
go back to reference Dallaire R (2004) Shake hands with the devil. Vintage Canada, Toronto, pp 520–1 Dallaire R (2004) Shake hands with the devil. Vintage Canada, Toronto, pp 520–1
10.
go back to reference WHO (2003) STEPS: a framework for surveillance. World Health Organization, Geneva WHO (2003) STEPS: a framework for surveillance. World Health Organization, Geneva
12.
go back to reference Sutcliffe SB (2010) From cancer care to cancer control: organization of population-based cancer control systems. In: Elwood M, Sutcliffe SB (eds) cancer control. Oxford, Oxford University Press, pp 279–296 Sutcliffe SB (2010) From cancer care to cancer control: organization of population-based cancer control systems. In: Elwood M, Sutcliffe SB (eds) cancer control. Oxford, Oxford University Press, pp 279–296
Metadata
Title
Cancer control—a global challenge requiring collaborative solutions
Author
Simon B. Sutcliffe
Publication date
01-04-2011
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 4/2011
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-011-1098-8

Other articles of this Issue 4/2011

Supportive Care in Cancer 4/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine